Key Words
Secondary surgical procedure - TEVAR - Aorto-esophageal fistula - Case description
Introduction
We present the case of a 56-year-old patient who underwent replacement of the ascending
aorta and aortic arch due to acute Type A dissection at an external department. The
patient suffered from arterial hypertension and unilateral paresis of the recurrent
laryngeal nerve after the primary surgery.
During follow-up, the patient showed a progressive aneurysm of the descending aorta
and was therefore treated with subclavian transposition in combination with thoracic
endovascular aortic repair (TEVAR) (Medtronic Valiant, 42 × 100, Medtronic Vascular,
Santa Rosa, CA) 8 months after emergency surgery. Two months after TEVAR the patient
was readmitted with hematemesis and significant blood loss. Computer tomography (CT)
scan revealed contained rupture of the descending aorta distal to the stent graft.
The patient then again underwent TEVAR (Medtronic Valiant, 42 × 140, Medtronic Vascular,
Santa Rosa, CA) for distal elongation of the stent graft in an emergency setting.
Gastroscopy revealed erosion of the esophagus, which was treated with an esophageal
stent placement. Ten days after TEVAR and esophageal stent placement, control gastroscopy
was performed and the patient was discharged home under stable conditions.
One month after the second intervention the patient was scheduled for removal of the
esophageal stent. Gastroscopy after removal of the stent revealed a large defect in
the esophagus with an aorto-esophageal fistula, covering approximately a third of
the esophageal circumference ([Fig. 1]). Based on these findings, a CT scan was performed, which confirmed the diagnosis
of an aorto-esophageal fistula with signs of mediastinitis ([Fig. 1]).
Figure 1. (A) CT scan revealing migration of the stent graft into the esophageal wall. (B)
Gastroscopic finding showing a big defect of the esophageal wall and presence of an
aorto-esophageal fistula.
At this time point the patient was stable and was transferred to our center for surgical
repair. Preoperatively, a percutaneous endoscopic gastrostomy (PEG) tube was placed
due to the planned surgical esophagectomy. Through left lateral thoracotomy the aorto-esophageal
fistula was identified ([Fig. 2]). The patient was placed on femoral-femoral bypass through the groin vessels. The
descending aorta was clamped distal to the aortic arch and proximal to the diaphragm.
As a first step, evaluation of the defect of the esophageal wall was performed. As
the fistula covered nearly half of the esophageal circumference, resection of about
8 cm of the esophagus was performed with a stapling method (Endo-GIA, blue cartridge,
Covidien Intl., Mansfield, MA). The descending aorta was transected and the two stent
grafts could successfully be removed. Due to infection risk of the surrounding tissue,
a biological replacement of the descending aorta was performed using a pericardial
patch ([Fig. 3]). The aortic graft was de-aired and the aortic cross-clamp was removed after 124
minutes. The patient was weaned from bypass after 140 minutes. After successful partial
esophagectomy and descending aortic replacement, a cervical salivary fistula (T-Tube,
12F) was created via a left cervical approach and the patient was taken to the intensive
care unit (ICU).
Figure 2. Intraoperative view of defect in the esophagus and aortic wall.
Figure 3. Descending aortic replacement using a pericardial tube.
The patient had a complicated and long postoperative recovery at the ICU, requiring
reintubation and tracheotomy on the 12th postoperative day. He suffered from two episodes
of pneumonia presumably due to aspiration and received extensive antibiotic treatment.
Three months after esophagectomy, a reconstruction of the esophagus was performed
by gastric tube pull up with a stapled (CEEA, blue load, Covidien, Intl., Mansfield,
MA) end-to-side esophagogastrostomy, a pyloromyotomy, and a jejunal catheter placement.
Nearly 4 months after descending aortic replacement, the patient recovered completely
without wound healing disorders. He was in a stable respiratory state and could be
discharged without neurologic impairment and in stable condition.
The patient was seen in outpatient clinic for a follow-up visit 6 months after descending
replacement. He was still in recovery with complaints about pain along the thoracotomy
wound. Furthermore, the patient was still in a cachectic nutritional status.
Discussion
Secondary surgical interventions after TEVAR are needed in 2.2-7.4% of all patients[1]
[2]. While overall mortality in those challenging cases ranges from 11.5 to 19%, survival
of patients undergoing surgery due to aorto-esophageal fistula is still very poor[2]–[6]. Muradi et al.[7] summarized published cases on secondary aorto-esophageal fistula after TEVAR and
reported a mortality of 75%. Analysis of 36 patients in the European registry of endovascular
aortic repair also pointed out the high mortality of this devastating complication
and the best 1-year survival rate in patients undergoing aggressive surgical treatment[6].
The mechanisms of aorto-esophageal fistula might consist of a combination of stent
graft coverage of the arteries in the midesophageal segment causing ischemic necrosis
or, in cases of contained rupture, possible development of a resorption hematoma leading
to wall fatigue of the esophagus[1]
[2]. Further hypotheses on the pathomechanism include direct erosion of the relatively
rigid stent graft through the aortic wall into the esophagus, pressure necrosis of
the esophageal wall due to the continuing forces of self-expanding endoprosthesis,
and infection of stent graft prosthesis leading to erosion of the esophageal wall[5]. Opening the mediastinal pleura via lateral thoracotomy and decompressing the posterior
mediastinum could emerge as a preventive treatment[2].
In this case, development of the aorto-esophageal fistula was most probably based
on a combination of different mechanisms. Erosion of the esophagus occurred probably
due to ischemia induced by a resorption hematoma of the descending aorta in the first
instance. By placing an esophageal stent, malperfusion of the esophageal wall was
aggravated and finally resulted in a pressure necrosis induced by the forces of two
self-expanding devices. The patient was initially treated at an external department
and was transferred for treatment of the aorto-esophageal fistula to our department.
Occurrence of esophageal erosion after TEVAR was probably the first sign of malperfusion
and impending fistulation. In accordance with published data, the esophageal stenting-only
approach is associated with poor 1-year survival of only 17%[6]. After confirmation of aorto-esophageal fistula, aggressive surgical treatment was
chosen, which finally resulted in a prolonged and complicated hospital stay and survival
of the patient.
Similar cases are described in the literature using either a bovine pericardial patch
or other material for descending replacement, such as silver-coated polyester grafts
or autografts[3]
[4]
[6]. All these materials aim to avoid Dacron grafts, which might be at higher risk for
reinfection. Removing all infected material, performing extensive debridement, and
using a self-made pericardial tube as neoarta provides excellent and durable results[8].